Better cancer therapies by identifying oncogenes, David Botstein
Interviewee: David Botstein.
David Botstein discusses how identifying the molecular mechanisms of cancer will lead to the development of improved therapies.
(DNAi Location: Applications > Genes and medicine > Genetic profiling > David Botstein
There are also gene expression patterns that are characteristic of particular kinds of oncogene activities and then if you can identify the oncogene that is characteristically over expressed or poorly expressed in a particular tumor, you can then make drugs against it and Gleevec™ and Iressa™ are drugs of that kind.